Heart failure, disease management systems, ICT guided protocols, telemonitoring, telemedicine, telecare, cost effectiveness
Conditions
Interventions
1. ICT guided disease management without telemedicine.
Patients will receive care with an ICT guided disease management system (CardioConsult). The patient will also recieve tailored information on li
2. ICT guided disease management with telemedicine.
The above described disease management system will function together with telemedicine devices (weightscale, ECG, healthmonitor and blood pressure m
Sponsors
University Medical Center Groningen (UMCG), department of cardiology
Eligibility
Inclusion criteria
Inclusion criteria: Patients are eligible when they are admitted to the IC/CCU or cardiology ward for heart failure, NYHA class III-IV, have evidence for structural underlying heart disease, are intravenously treated with diuretics during their hospitalisation, have a documented ejection fraction less or equal than 40% in the previous 3 months, are at least 18 years old, male or female and are able to understand content of and willing to provide informed consent.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the study when they have a history of myocardial infarction in the previous 1 month, have a life expectation less then 1 year, have a history of valve replacement or surgery within the previous 6 months, have undergone cardiac invasive intervention within the last 6 months or planned to have such a procedure in the following 3 months, are evaluated for heart transplantation prior or during the study, are inable to fill out questionnaires, are inable to use telemedicine devices at home or participate at another clinical intervention trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. A composite end point for death; 2. Readmission for heartfailure; 3. Change in quality of life. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Death from any cause; 2. First readmission for heart failure; 3. Change in quality of life; 4. Treatment according to guidelines; 5. Optimal dosage of medication; 6. Number of visits to the heart failure clinic; 7. HF knowledge and self-care behaviour; 8. Cost-benefit ratio. | — |
Contacts
Public ContactA.E. Vries, de
Department of Cardiology University Medical Center Groningen
Outcome results
None listed